We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Immunization with recombinant <italic>Salmonella</italic> expressing SspH2-EscI protects mice against wild type <italic>Salmonella</italic> infection.
- Authors
Hu, Maozhi; Zhao, Weixin; Li, Hongying; Gu, Jie; Yan, Qiuxiang; Zhou, Xiaohui; Pan, Zhiming; Cui, Guiyou; Jiao, Xinan
- Abstract
Background: Enhancing caspase-1 activation in macrophages is helpful for the clearance of intracellular bacteria in mice. Our previous studies have shown that EscI, an inner rod protein of type III system in <italic>E. coli</italic> can enhance caspase-1 activation. The purpose of this study was to further analyze the prospect of EscI in the vaccine design. Results: A recombinant <italic>Salmonella</italic> expressing SspH2-EscI fusion protein using the promotor of <italic>Salmonella</italic> effector SspH2, X4550(pYA3334-P-SspH2-EscI), was constructed. A control recombinant <italic>Salmonella</italic> expressing SspH2 only X4550(pYA3334-P-SspH2) was also constructed. In the early stage of in vitro infection of mouse peritoneal macrophages, X4550(pYA3334-P-SspH2-EscI) could significantly (<italic>P</italic> < 0.05) enhance intracellular caspase-1 activation and pyroptotic cell death of macrophages, when compared with X4550(pYA3334-P-SspH2). Except for the intracellular pH value, the levels of reactive oxygen species, intracellular concentration of calcium ions, nitric oxide and mitochondrial membrane potential in macrophages were not significantly different between the cells infected with X4550(pYA3334-P-SspH2-EscI) and those infected with X4550(pYA3334-P-SspH2). Besides, only lower inflammatory cytokines secretion was induced by X4550(pYA3334-P-SspH2-EscI) than X4550(pYA3334-P-SspH2). After intravenous immunization of mice (1 × 106 cfu/mouse), the colonization of X4550(pYA3334-P-SspH2-EscI) in mice was significantly limited at one week post immunization (wpi), when compared with X4550(pYA3334-P-SspH2) (<italic>P</italic> < 0.05). The population of activated CD8+T lymphocytes in mouse spleens induced by X4550(pYA3334-P-SspH2-EscI) was lower than that induced by X4550(pYA3334-P-SspH2) at 2–3 wpi, and the ratio of CD4+T cells to CD8+T cells decreased. The blood coagulation assay indicated that no significant difference was found between X4550(pYA3334-P-SspH2-EscI) and uninfected control, while X4550(pYA3334-P-SspH2) could induce the quick coagulation. Notably, immunization of X4550(pYA3334-P-SspH2-EscI) could limit the colonization of challenged <italic>Salmonella</italic> strains in the early stage of infection and provide more effective protection. Conclusion: The activation of caspase-1 in macrophages by EscI can be used in the design of live attenuated <italic>Salmonella</italic> vaccine candidate.
- Subjects
SALMONELLA typhimurium; IMMUNE response; MICROBIAL virulence; LABORATORY mice; ENTEROBACTERIACEAE
- Publication
BMC Veterinary Research, 2018, Vol 14, p1
- ISSN
1746-6148
- Publication type
Article
- DOI
10.1186/s12917-018-1404-5